Bone cancer, while rare, can be quite serious. Acupath Laboratories, Inc. would like to share some key points based on information available: Statistics and Types of Bone Cancer: • Incidence: Primary bone cancers are very uncommon, comprising less than 1% of all cancers. • Gender Differences: In 2024, an estimated 3,970 new cases of primary...
What are the differences between urinalysis, urine cytology, and the AcuURO-17? While urine cytology, urinalysis, and AcuURO-17 are all diagnostic tests that involve urine, they are quite different. Urinalysis and urine cytology indeed play crucial roles and are essential diagnostic tools in the field of urology and contribute significantly to the early detection and management...
Bringing together Acupath and AIRA Matrix, Lumea leverages its advanced tech to facilitate collaboration in digital pathology. LEHI, UTAH, UNITED STATES, March 25, 2024 /EINPresswire.com/ — The combined collaboration of these three innovative companies marks a significant leap forward in digital pathology collaboration and adoption. Each is an industry leader in their own right—Lumea, the...
© 2024 Acupath Laboratories. All rights reserved
